Alamar Biosciences (NASDAQ:ALMR) CEO and co-founder Yuling Luo said the company is seeking to establish “a new gold standard in protein detection and analysis” through its precision proteomics platform, emphasizing rapid commercial adoption, strong use in Alzheimer’s disease research and a longer-term path toward diagnostics. Speaking at a Bank of America Life Science Tools and […]